XML 27 R16.htm IDEA: XBRL DOCUMENT v3.10.0.1
Share-based compensation
9 Months Ended
Sep. 30, 2018
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Share-based compensation

10. Share-based compensation

The following tables present the detail of share-based compensation by line item in the condensed consolidated statements of operations and comprehensive income (loss) as well as by award type:

 

 

 

Three Months Ended

September 30,

 

 

Nine Months Ended

September 30,

 

(U.S. Dollars, in thousands)

 

2018

 

 

2017

 

 

2018

 

 

2017

 

Cost of sales

 

$

151

 

 

$

151

 

 

$

408

 

 

$

437

 

Sales and marketing

 

 

514

 

 

 

394

 

 

 

1,436

 

 

 

1,073

 

General and administrative

 

 

4,194

 

 

 

2,828

 

 

 

11,488

 

 

 

6,935

 

Research and development

 

 

402

 

 

 

259

 

 

 

1,060

 

 

 

679

 

Total

 

$

5,261

 

 

$

3,632

 

 

$

14,392

 

 

$

9,124

 

 

 

 

Three Months Ended

September 30,

 

 

Nine Months Ended

September 30,

 

(U.S. Dollars, in thousands)

 

2018

 

 

2017

 

 

2018

 

 

2017

 

Stock options

 

$

579

 

 

$

684

 

 

$

2,442

 

 

$

1,802

 

Time-based restricted stock awards and units

 

 

2,244

 

 

 

1,552

 

 

 

5,480

 

 

 

4,083

 

Performance-based restricted stock awards and units

 

 

734

 

 

 

115

 

 

 

1,493

 

 

 

340

 

Market-based restricted stock units

 

 

1,298

 

 

 

997

 

 

 

3,855

 

 

 

1,935

 

Stock purchase plan

 

 

406

 

 

 

284

 

 

 

1,122

 

 

 

964

 

Total

 

$

5,261

 

 

$

3,632

 

 

$

14,392

 

 

$

9,124

 

During the three months ended September 30, 2018 and 2017, the Company issued 50,928 and 93,486 shares, respectively, of common stock related to stock option exercises and the vesting of restricted stock awards. During the nine months ended September 30, 2018 and 2017, the Company issued 257,883 and 384,761 shares, respectively, of common stock related to stock purchase plan issuances, stock option exercises and the vesting of restricted stock awards.